Latest news with #HoldRating
Globe and Mail
12-07-2025
- Business
- Globe and Mail
BTIG Remains a Hold on Palo Alto Networks (PANW)
BTIG analyst Gray Powell maintained a Hold rating on Palo Alto Networks yesterday. The company's shares closed yesterday at $192.07. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Powell is a 5-star analyst with an average return of 10.1% and a 56.59% success rate. Powell covers the Technology sector, focusing on stocks such as Zscaler, Palo Alto Networks, and Snowflake. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Palo Alto Networks with a $217.71 average price target. PANW market cap is currently $137.4B and has a P/E ratio of 109.91. Based on the recent corporate insider activity of 116 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PANW in relation to earlier this year. Earlier this month, Aparna Bawa, a Director at PANW sold 526.00 shares for a total of $99,940.00.
Globe and Mail
10-07-2025
- Business
- Globe and Mail
Wells Fargo Remains a Hold on CoreWeave, Inc. Class A (CRWV)
In a report released yesterday, Michael Turrin from Wells Fargo maintained a Hold rating on CoreWeave, Inc. Class A, with a price target of $60.00. The company's shares closed yesterday at $159.70. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Turrin is a 3-star analyst with an average return of 1.8% and a 51.47% success rate. Turrin covers the Technology sector, focusing on stocks such as Microsoft, CoreWeave, Inc. Class A, and DocuSign. CoreWeave, Inc. Class A has an analyst consensus of Moderate Buy, with a price target consensus of $78.53, representing a -50.83% downside. In a report released today, Barclays also maintained a Hold rating on the stock with a $100.00 price target. The company has a one-year high of $187.00 and a one-year low of $33.52. Currently, CoreWeave, Inc. Class A has an average volume of 20.54M. Based on the recent corporate insider activity of 26 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CRWV in relation to earlier this year.
Globe and Mail
10-07-2025
- Business
- Globe and Mail
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline today and set a price target of £14.50. The company's shares closed yesterday at p1,414.00. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Field is an analyst with an average return of -2.1% and a 37.76% success rate. Field covers the Healthcare sector, focusing on stocks such as GlaxoSmithKline, AstraZeneca, and Roche Holding AG. In addition to Barclays, GlaxoSmithKline also received a Hold from Deutsche Bank 's Emmanuel Papadakis in a report issued yesterday. However, on June 30, J.P. Morgan maintained a Sell rating on GlaxoSmithKline (LSE: GSK). Based on GlaxoSmithKline's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of p7.52 billion and a net profit of p1.62 billion. In comparison, last year the company earned a revenue of p7.36 billion and had a net profit of p1.05 billion Based on the recent corporate insider activity of 311 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GSK in relation to earlier this year.
Globe and Mail
08-07-2025
- Business
- Globe and Mail
Raymond James Financial (RJF) Receives a Rating Update from a Top Analyst
Citi analyst Christopher Allen maintained a Hold rating on Raymond James Financial today and set a price target of $165.00. The company's shares closed last Thursday at $160.00. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Allen covers the Financial sector, focusing on stocks such as Charles Schwab, BlackRock, and Interactive Brokers. According to TipRanks, Allen has an average return of 28.6% and an 82.38% success rate on recommended stocks. Raymond James Financial has an analyst consensus of Moderate Buy, with a price target consensus of $155.10, which is a -3.06% downside from current levels. In a report released on June 26, TD Cowen also maintained a Hold rating on the stock with a $152.00 price target. Based on Raymond James Financial's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $3.79 billion and a net profit of $495 million. In comparison, last year the company earned a revenue of $3.61 billion and had a net profit of $475 million Based on the recent corporate insider activity of 69 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of RJF in relation to earlier this year. Most recently, in May 2025, Bella Loykhter Allaire, the Chief Admin Officer of RJF sold 6,570.00 shares for a total of $963,227.70.
Globe and Mail
01-07-2025
- Business
- Globe and Mail
Bayer (0P6S) Gets a Hold from J.P. Morgan
J.P. Morgan analyst Richard Vosser maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €25.00. The company's shares closed last Friday at €26.70. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Vosser is a 3-star analyst with an average return of 2.6% and a 47.09% success rate. Vosser covers the Healthcare sector, focusing on stocks such as Novo Nordisk, Roche Holding AG, and Bayer. In addition to J.P. Morgan, Bayer also received a Hold from Jefferies's Charles Bentley, CFA in a report issued today. However, on June 24, DZ BANK AG maintained a Buy rating on Bayer (LSE: 0P6S). Based on Bayer's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of €13.74 billion and a net profit of €1.3 billion. In comparison, last year the company earned a revenue of €13.77 billion and had a net profit of €2 billion
